MedPath

Early Administration of Bifidobacterium to Very Low Birth Weight Infants

Not Applicable
Completed
Conditions
Preterm Infants
Interventions
Dietary Supplement: Administration of Bifidobacterium bifidum
Registration Number
NCT01330095
Lead Sponsor
Tokyo Women's Medical University
Brief Summary

To evaluate the effects of early administration of probiotics on acceleration of enteral feeding, and on growth of very low birth weight infants, newborn infants with birth weight less than 1500g are administered Bifidobacterium bifidum twice a day.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
36
Inclusion Criteria
  • Very low birth weight infant
Read More
Exclusion Criteria
  • Presence of major congenital malformations
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Eearly administrationAdministration of Bifidobacterium bifidumAdministration of Bifidobacterium within 48h after birth
Late administrationAdministration of Bifidobacterium bifidumAdministration of Bifidobacterium more than 48h after birth
Primary Outcome Measures
NameTimeMethod
the day at total feeding volume reached 100ml/kg/daypost natal day

the post natal day at total enteral feeding reached 100ml/kg/day

Secondary Outcome Measures
NameTimeMethod
colonizatin of Bifidobacterium4 weeks after birth

the level of Bifidobacterium in feces from the study infants growth rate of the study infants the positive rate of MRSA colonization among the study infants adverse outcomes

Trial Locations

Locations (1)

Tokyo Women's Medical Unversity

🇯🇵

Shinjuku, Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath